Artificial intelligence for non-invasive glycaemic-events detection via ECG in a paediatric population: study protocol
Open Access
- 23 January 2023
- journal article
- research article
- Published by Springer Nature in Health and Technology
- Vol. 13 (1) , 145-154
Abstract
Purpose: Paediatric Type 1 Diabetes (T1D) patients are at greater risk for developing severe hypo and hyperglycaemic events due to poor glycaemic control. To reduce the risk of adverse events, patients need to achieve the best possible glycaemic management through frequent blood glucose monitoring with finger prick or Continuous Glucose Monitoring (CGM) systems. However, several non-invasive techniques have been proposed aiming at exploiting changes in physiological parameters based on glucose levels. The overall objective of this study is to validate an artificial intelligence (AI) based algorithm to detect glycaemic events using ECG signals collected through non-invasive device. Methods: This study will enrol T1D paediatric participants who already use CGM. Participants will wear an additional non-invasive wearable device for recording physiological data and respiratory rate. Glycaemic measurements driven through ECG variables are the main outcomes. Data collected will be used to design, develop and validate the personalised and generalized classifiers based on a deep learning (DL) AI algorithm, able to automatically detect hypoglycaemic events by using few ECG heartbeats recorded with wearable devices. Results: Data collection is expected to be completed approximately by June 2023. It is expected that sufficient data will be collected to develop and validate the AI algorithm. Conclusion: This is a validation study that will perform additional tests on a larger diabetes sample population to validate the previous pilot results that were based on four healthy adults, providing evidence on the reliability of the AI algorithm in detecting glycaemic events in paediatric diabetic patients in free-living conditions. Trial registration: ClinicalTrials.gov identifier: NCT03936634. Registered on 11 March 2022, retrospectively registered, https://www.clinicaltrials.gov/ct2/show/NCT05278143?titles=AI+for+Glycemic+Events+Detection+Via+ECG+in+a+Pediatric+Population&draw=2&rank=1.Keywords
Funding Information
- Wellcome Trust (WT-219429/Z/19/Z)
This publication has 50 references indexed in Scilit:
- The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trialDiabetologia, 2012
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 DiabetesDiabetes Care, 2011
- Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetesPediatric Diabetes, 2011
- Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 DiabetesNew England Journal of Medicine, 2010
- Health-Related Quality of Life Across Pediatric Chronic ConditionsThe Journal of Pediatrics, 2010
- Free-living inferential modeling of blood glucose level using only noninvasive inputsJournal of Process Control, 2010
- Incidencia de diabetes mellitus tipo 1 en niños: resultados del registro poblacional de la Comunidad de Madrid, 1997–2005Medicina Clinica, 2009
- Type 1 Diabetes Mellitus in PediatricsPediatrics in Review, 2008
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008
- Worldwide childhood type 1 diabetes incidence ? what can we learn from epidemiology?Pediatric Diabetes, 2007